Nath Bio-Genes posts Rs 32.26 cr Q1 profit at 10.7% margin
The consolidated result reflects a low 2.19% tax rate, while other income was not the main source of pre-tax profit.
Filed 29 Jul 2026, 16:22 IST · after market close · NATHBIOGEN (NATHBIOGEN)
Key takeaways
- Nath Bio-Genes reported consolidated Q1FY27 operating profit of Rs 35.15 cr on revenue of Rs 328.4 cr, with a 10.7% operating margin.
- Net profit was Rs 32.26 cr, helped by a 2.19% tax rate and a tax charge of only Rs 0.72 cr.
- Other income of Rs 3.1 cr was modest relative to profit before tax of Rs 32.98 cr, while EPS stood at Rs 16.98.
Q1FY27 operating outcome
Nath Bio-Genes generated consolidated operating profit of Rs 35.15 cr from revenue of Rs 328.4 cr. The resulting 10.7% operating margin sets the starting point for assessing execution in subsequent quarters.
Low tax rate shaped reported profit
The Rs 32.26 cr net profit was supported by a 2.19% tax rate, which kept the tax charge at Rs 0.72 cr. Other income contributed Rs 3.1 cr, while interest cost was Rs 4.26 cr, so the reported profit was not mainly dependent on other income.
Results filed after market close
The company filed its consolidated Q1FY27 results after market close on 29 Jul 2026. With no quarter-on-quarter or year-on-year comparison provided, the next reported period will establish the direction of revenue, margin and tax normalisation.
Q1FY27 at a glance
Consolidated figures as filed with NSE — filed ahead of third-party databases, not yet independently cross-checked.
| Line item | Q1FY27 |
|---|---|
| Revenue | ₹328 cr |
| Other income | ₹3 cr |
| Expenses | ₹293 cr |
| Operating profit | ₹35 cr |
| Operating margin (%) | 10.70% |
| Interest | ₹4 cr |
| Depreciation | ₹1 cr |
| Profit before tax | ₹33 cr |
| Tax | ₹1 cr |
| Net profit | ₹32 cr |
| EPS (₹) | ₹16.98 |
What to watch
- Whether operating margin holds around the reported 10.7%.
- Whether the tax rate remains near 2.19% or moves higher.
- Whether revenue builds from Rs 328.4 cr in the next reported quarter.